Jeffrey B. Korn

• Jeff serves as a member of the Board of Visitors of the Columbia School of Law.
• Jeff previously served as Vice-Chair of the Exemptions and Immunities Committee and of the Books and Treatises Committee of the Section of Antitrust Law of the American Bar Association.
• Jeff’s publications include:  Proof of Conspiracy Under Federal Antitrust Law (co-edited); “If At First You Don’t Succeed: The Use Of Scheme Liability After Janus,” Investment Lawyer (March 2013); “Gallus Revisited: Summary Judgment After Jones v. Harris,” Investment Lawyer (Sept. 2012); “Jones v. Harris: Eighteen Months Later,” Investment Lawyer (Nov. 2011); eDiscovery for Corporate Counsel (contributing author); and “Competitive Information Sharing In Merger Negotiations: How Much Is Too Much?,” Wall Street Lawyer (April 2007) (co-authored with Katherine Forrest).

Antitrust Litigation and Counseling

• Regularly counsels clients in connection with significant M&A and litigation matters across a wide range of industries including financial information technology, pharmaceuticals, airlines, retail, telecommunications, insurance and banking
• Tropicana – Represented PAI Partners in connection with its $3.3 billion acquisition of Tropicana, Naked and other select juice brands across North America from PepsiCo, Inc.
• Imperfect Foods/Misfits Markets – Represented a private equity firm in its investment in Imperfect Foods in connection with Misfits Markets’ acquisition of Imperfect Foods  
• MedAssets, Inc. – Represented MedAssets in its acquisition by Pamplona Capital Management and Vizient, Inc. for $2.7 billion
• BB&T – Represented BB&T in its acquisition of Swett & Crawford for $500 million
• MetLife – Represented MetLife in its sale of its national distribution salesforce to MassMutual
• Hudson's Bay Company – Represented Hudson's Bay, which owns Lord & Taylor, in its $2.9 billion acquisition of Saks Incorporated
• Tornier, Inc. – Represented Tornier in its acquisition by Wright Medical Group and approval following second request and consensual divestitures with FTC
• The Men’s Wearhouse – Represented The Men’s Wearhouse in securing unconditional approval of its acquisition of Jos. A. Bank following second request investigation by FTC
• Pearl Therapeutics – Represented Pearl in its $1.15 billion sale to AstraZeneca to strengthen its respiratory products portfolio
• In the Matter of Polypore International, Inc. – Represented divestiture buyer in required divestiture of Microporous following post-closing investigation and trial
• In re Modafinil Antitrust Litigation - Represented pharmaceutical company in class action antitrust litigation and FTC investigation arising from settlement of patent litigation (E.D. Pa.)
• In re Nifedipine Antitrust Litigation - Represented pharmaceutical company in class action antitrust litigation relating to distribution of generic nifedipine in the United States (D.D.C.)
• State of Ohio v. American International Group, et al. - Represented insurance broker in antitrust enforcement and damages action brought by the Ohio Attorney General arising from alleged industry-wide conspiracy (Ohio Ct. Com. Pl.)
• Clayworth v. Pfizer – Represented pharmaceutical company in action brought under California’s Cartwright Act arising from alleged industry-wide price fixing conspiracy (Cal.)

Securities and M&A Litigation

• City of Hialeah Employees' Retirement System v. Insight Venture Partners, LLC – Secured the dismissal of a shareholder litigation challenging a $1.2 billion acquisition (Del. Ch.)
• White Mountains v. The Allstate Corporation – Obtained dismissal of action against buyer and then represented buyer in purchase price adjustment dispute in arbitration 
• In re Quest Software, Inc. Shareholder Litig. - Represented private equity buyer in litigation arising out of $2 billion “going private” transaction (Del., Cal.)
• In re AboveNet, Inc. Shareholder Litig. - Represented target and board of directors in litigation arising out of $2 billion merger transaction (Del., N.Y.)
• In re Cogdell Shareholder Litig. - Represented REIT acquiror in litigation arising out of $765 million acquisition (Md., N.C.)
• In re Transatlantic Shareholders Litig. - Represented potential acquiror in litigation brought by shareholders and competing bidder arising out of $3 billion merger (Del., N.Y.)
• NetCoalition v. SEC - Represented NetCoalition in appeal challenging reasonableness of fees for market data (D.C. Cir.)
• Abu Dhabi Commercial Bank v. Morgan Stanley & Co., et al. - Represented hedge fund in securities class action arising from collapse of structured investment vehicle during recent credit crisis (S.D.N.Y.)
• In re The Reserve Fund Securities Litig. and Related Actions - Represented money market mutual fund in high-profile “break the buck” litigation in more than 40 separate class, individual, and derivative lawsuits brought by investors in state and federal courts throughout the country (MDL)
• In re Enron Securities Litig. and Related Actions - Represented major financial institution in all Enron-related actions (MDL)
• In re Lucent Technologies, Inc. Securities Litig. - Represented telecommunications company in connection with numerous lawsuits and related SEC investigation (D.N.J.)
• In re Builders Firstsource, Inc. Shareholders & Derivative Litigation - Represented private equity firm in shareholder challenge to proposed recapitalization of company (Del. Ch.)
• Bay Harbour Management LLC v. Carothers, et al. – Represented officers of bankrupt furniture company in securities lawsuit brought in connection with debt securities offering (S.D.N.Y.)

Other Complex Commercial Litigation

• Deepwater Horizon litigation – Obtained summary judgment, affirmed on appeal, for client in multidistrict litigation arising out of Deepwater Horizon oil spill
• RICO class action litigation – Representing insurer in nationwide class action alleging violations of RICO in connection with reinsurance transactions
• Private equity litigation – Regularly represents private equity funds and their portfolio companies in a wide variety of complex commercial business disputes